ORAGENICS INC
ORAGENICS INC (OGEN): 1 pipeline candidate · ~9 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
8.9 months
D/E 0.21 · 0% dilution
Lead: Phase 2
1 candidate
N/A
N/A
A transparent, data-derived signal for ORAGENICS INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$2.8M
Cash
$6.1M
Quarterly Burn
$2.2M
Runway
8.9 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| onp-002 | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
15
Total value held
$48K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 65,072 | $36K |
| two sigma securities, llc | 20,343 | $11K |
| blackrock, inc. | 703 | $394 |
| st. johns investment management company, llc | 200 | $112 |
| harbour investments, inc. | 34 | $19 |
| wells fargo & company/mn | 34 | $19 |
| hrt financial lp | 18,672 | $10 |
| sbi securities co., ltd. | 11 | $6 |
| bogart wealth, llc | 1 | $1 |
| farther finance advisors, llc | 1 | $1 |
Showing top 10 of 15 institutional holders of ORAGENICS INC. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ORAGENICS INC's pipeline?
ORAGENICS INC (OGEN) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is ORAGENICS INC's lead drug candidate?
ORAGENICS INC's most advanced tracked candidate is onp-002 (Phase 2) for mild traumatic brain injury ("mTBI" or "concussion").
What is ORAGENICS INC's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ORAGENICS INC has approximately 8.9 months of cash runway.
What is ORAGENICS INC's market capitalization?
ORAGENICS INC's market capitalization is approximately $2.8M.
Who is the CEO of ORAGENICS INC?
Ms. Janet Huffman is the chief executive officer of ORAGENICS INC (OGEN).
Get the full picture on ORAGENICS INC
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.